Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roniel Cabrera

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantationRoberto J Firpi, Haizhen Zhu, Giuseppe Morelli, et al.
Abdominal Radiology (New York)|October 21, 2017
Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinomaAltan F Ahmed, Naziya Samreen, Joseph R Grajo, et al.
World Journal of Hepatology|April 10, 2023
Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experienceWilliam W King, Raymond Richhart, Tyler Culpepper, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infectionRoberto J Firpi, Manal F Abdelmalek, Consuelo Soldevila-Pico, et al.
Journal of Hepatocellular Carcinoma|July 25, 2023
Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone MetastasisMuhammet Ozer, Suleyman Yasin Goksu, Rick Y Lin, et al.
Journal of Viral Hepatitis|January 17, 2025
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral TherapyAmit G Singal, K Rajender Reddy, Massimo Colombo, et al.
American Journal of Clinical Oncology|February 22, 2020
Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver TransplantationAndreas G Zori, Media N Ismael, Alpna R Limaye, et al.
Journal of Hepatology|April 29, 2018
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trialRichard S Finn, Philippe Merle, Alessandro Granito, et al.
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
Hepatology (Baltimore, Md.)|November 10, 2025
A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinomaAnthony B El-Khoueiry, Richard D Kim, William P Harris, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantationRoberto J Firpi, Haizhen Zhu, Giuseppe Morelli, et al.
Abdominal Radiology (New York)|October 21, 2017
Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinomaAltan F Ahmed, Naziya Samreen, Joseph R Grajo, et al.
World Journal of Hepatology|April 10, 2023
Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experienceWilliam W King, Raymond Richhart, Tyler Culpepper, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infectionRoberto J Firpi, Manal F Abdelmalek, Consuelo Soldevila-Pico, et al.
Journal of Hepatocellular Carcinoma|July 25, 2023
Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone MetastasisMuhammet Ozer, Suleyman Yasin Goksu, Rick Y Lin, et al.
Journal of Viral Hepatitis|January 17, 2025
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral TherapyAmit G Singal, K Rajender Reddy, Massimo Colombo, et al.
American Journal of Clinical Oncology|February 22, 2020
Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver TransplantationAndreas G Zori, Media N Ismael, Alpna R Limaye, et al.
Journal of Hepatology|April 29, 2018
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trialRichard S Finn, Philippe Merle, Alessandro Granito, et al.
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
Hepatology (Baltimore, Md.)|November 10, 2025
A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinomaAnthony B El-Khoueiry, Richard D Kim, William P Harris, et al.
Pageof 7